Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury

Obajdin, J; Cotter, M; Snelling, S; Dremier, S; De Ron, P; Fleurance, R; Valentin, JP; da Costa, AN; Gryshkova, V

Gryshkova, V (reprint author), UCB Biopharma SPRL, Dev Sci, Invest Toxicol, Bldg R9, B-1420 Braine Lalleud, Belgium.

TOXICOLOGICAL SCIENCES, 2018; 166 (2): 441

Abstract

Identification of improved translatable biomarkers of nephrotoxicity is an unmet safety biomarker need. Fatty-acid-binding protein 4 (FABP4) was previ......

Full Text Link